| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,621 |
4,573 |
$190K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,853 |
7,699 |
$122K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,389 |
5,346 |
$112K |
| 71046 |
Radiologic examination, chest; 2 views |
17,471 |
17,307 |
$102K |
| 71045 |
Radiologic examination, chest; single view |
19,976 |
18,660 |
$75K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,141 |
5,111 |
$58K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
935 |
924 |
$21K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
612 |
603 |
$21K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
655 |
648 |
$12K |
| 71271 |
|
328 |
325 |
$7K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
374 |
371 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
114 |
113 |
$4K |
| 49083 |
|
23 |
12 |
$1K |
| 73630 |
|
228 |
201 |
$1K |
| 76536 |
|
71 |
71 |
$931.57 |
| 76770 |
|
61 |
61 |
$789.82 |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
62 |
61 |
$752.40 |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
15 |
14 |
$735.41 |
| 77065 |
Tomosynthesis, mammo |
24 |
24 |
$474.48 |
| 71250 |
|
24 |
24 |
$405.89 |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
12 |
12 |
$360.90 |
| 77080 |
|
132 |
131 |
$336.64 |
| 76642 |
|
15 |
14 |
$266.82 |
| 93971 |
|
25 |
25 |
$243.68 |
| 74018 |
|
54 |
53 |
$203.90 |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
13 |
$141.40 |
| 73030 |
|
12 |
12 |
$88.80 |
| 72100 |
|
12 |
12 |
$67.68 |
| 73610 |
|
12 |
12 |
$58.30 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,746 |
1,317 |
$0.00 |
| G9638 |
Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) |
38 |
31 |
$0.00 |